Unlocking Duel Benifits SGLT2i in CKD and Obesity

Mar
28
07:00 PM

This webinar explores the emerging role of SGLT2 inhibitors in the management of chronic kidney disease (CKD) and obesity. Experts will discuss the latest clinical evidence highlighting the dual benefits of these agents, including renal protection, cardiovascular outcomes, and metabolic improvements. Join us to gain insights into optimizing patient care with this evolving therapeutic approach

Panelists

Dr.Vikram Kalra

Additional Director, Department of Nephrology and Renal Transplant Medicine at Aakash Healthcare, Dwarka.

Unlocking Duel Benifits SGLT2i in CKD and Obesity

Mar
28
07:00 PM

This webinar explores the emerging role of SGLT2 inhibitors in the management of chronic kidney disease (CKD) and obesity. Experts will discuss the latest clinical evidence highlighting the dual benefits of these agents, including renal protection, cardiovascular outcomes, and metabolic improvements. Join us to gain insights into optimizing patient care with this evolving therapeutic approach

Panelists

Dr.Vikram Kalra

Additional Director, Department of Nephrology and Renal Transplant Medicine at Aakash Healthcare, Dwarka.

CONNECT WITH US

Archived Videos

loading..

CONNECT WITH US

Logo

Medtalks is India's fastest growing Healthcare Learning and Patient Education Platform designed and developed to help doctors and other medical professionals to cater educational and training needs and to discover, discuss and learn the latest and best practices across 100+ medical specialties. Also find India Healthcare Latest Health News & Updates on the India Healthcare at Medtalks

Quick Links

Useful Links

Medbytes FAQ
About Us
Medtalks TV
Contact Us
Webinars
Privacy Policy
CMEs
Terms And Conditions
Conferences

Connect With Us